Evaluation of the efficacy of Conbercept in the treatment of diabetic macular edema based on OCTA
Latest Information Update: 29 Sep 2020
At a glance
- Drugs Conbercept (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 28 Aug 2020 Planned number of patients changed from 100 to 120, according to trial deisgn published in the Medicine
- 28 Aug 2020 Trial design published in the Medicine
- 28 Aug 2020 According to trial design published in the Medicine, Progress of the trial (Till date: 6 July 2020), recruitment has started at all participating sites(n=7) and a total of 28 eyes have been recruited into the trial till date.